Is it safe to take a decongestant during pregnancy?

It is generally safe to take a decongestant during pregnancy after the first trimester, although it is best to obtain consent from the doctor first. Theoretically, the decongestant could cause adverse effects on the fetus due to vasoconstriction, but there is no clear connection in the studies. The doctor usually recommends a nasal spray decongestant during pregnancy because they are considered the lowest risk, although the use should be kept at a minimum. Decongestants pseudoephedrine and phenylephrine, commonly known as Sudafed® and Sudafed Pe®, are usually considered safe after the first trimester, although a pregnant woman should be aware of the possible effects on the fetus.

causes narrowing of the blood vessels in the body. This includes arteries in the uterus, reducing blood supply to the fetus. Theoretically, this could cause malformation and low birth weight of the fetus, although the studies have not found any clear evidence. Taking decongestants can also increase blood pressure that can be harmful to both the mother and the fetus, especially if the motherIt already has high blood pressure. Although conservative use of decongestants during pregnancy is generally safe, it is recommended that they consult a doctor before use before use.

The use of a local decongestant nasal spray during pregnancy, such as xylometazoline or oxymetazoline, is usually recommended on oral drugs due to low risks. Only about 5% to 10% of drugs are in fact absorbed into the bloodstream, and the study has not shown any increase in congenital defects using a decongestant with a nasal spray. It is recommended to use a spray only a few days at a time to prevent excessive use, as its use too often can cause symptoms to deteriorate or lead to addiction.

pseudoephedrine is an oral decongestant, which is often considered to be safe after the first trimester, because at this point there is no indication of fetal damage. Is marked as a cure of KategoRie B according to US food and drug administration. This means that animal drug tests showed low or no risks of fetus, but either there were not sufficient studies about people or studies, they did not confirm any significant risks to the human fetus.

Some studies have shown that pseudoephedrine taken during the first trimester can cause gastroschisis, which is when the intestines of the fetus stand out from the body. However, other studies have shown that there is no connection between them, so the risk of adopting a decongestant during pregnancy is considered very low. Similarly, phenylefrin is probably associated with minor fetal malformations during the first trimester, although enough studies on people have not been conducted to confirm the association.